Related Articles
Bortezomib improves adoptive carbonic anhydrase IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinoma
Specific growth inhibition of ErbB2‑expressing human breast cancer cells by genetically modified NK‑92 cells
Expression and characterization of cecropinXJ, a bioactive antimicrobial peptide from Bombyx mori (Bombycidae, Lepidoptera) in Escherichia coli
Cytokine-induced killer cells: A novel immunotherapy strategy for leukemia
CHARACTERIZATION OF SPONTANEOUS IMMUNOLOGICAL REGRESSION IN A HISTIOCYTOMA .1. ROLE OF NK CELLS AND ANTITUMOR ANTIBODIES